Joint (JYNT) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free JYNT Stock Alerts $12.23 +0.15 (+1.24%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Joint Short Interest DataCurrent Short Volume798,500 sharesPrevious Short Volume781,600 sharesChange Vs. Previous Month+2.16%Dollar Volume Sold Short$9.58 millionShort Interest Ratio / Days to Cover8.8Last Record DateApril 15, 2024Outstanding Shares14,940,000 sharesPercentage of Shares Shorted5.34%Today's Trading Volume22,943 sharesAverage Trading Volume52,442 sharesToday's Volume Vs. Average44% Short Selling Joint ? Sign up to receive the latest short interest report for Joint and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatJYNT Short Interest Over TimeJYNT Days to Cover Over TimeJYNT Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Joint Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024798,500 shares $9.58 million +2.2%N/A8.8 $12.00 3/31/2024781,600 shares $10.21 million -7.7%N/A8.1 $13.06 3/15/2024846,900 shares $10.80 million -10.8%N/A8.5 $12.75 2/29/2024949,000 shares $9.36 million -2.9%N/A9.2 $9.86 2/15/2024977,300 shares $10.17 million +5.2%N/A10.8 $10.41 1/31/2024928,900 shares $9.07 million +11.3%N/A8.5 $9.76 Get the Latest News and Ratings for JYNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024834,400 shares $7.55 million +12.9%N/A7.2 $9.05 12/31/2023738,900 shares $7.10 million +9.1%N/A6.2 $9.61 12/15/2023677,000 shares $6.29 million -6.3%N/A5.4 $9.29 11/30/2023722,100 shares $6.35 million +3.1%N/A4.9 $8.79 11/15/2023700,200 shares $6.02 million +18.9%N/A4.8 $8.60 10/31/2023589,100 shares $4.60 million -3.8%N/A3.4 $7.81 10/15/2023612,200 shares $4.98 million -16.0%N/A3.8 $8.13 9/30/2023728,400 shares $6.55 million -25.2%N/A4.6 $8.99 9/15/2023973,900 shares $9.33 million +3.4%6.9%6.5 $9.58 8/31/2023942,100 shares $8.75 million +8.0%6.6%7.5 $9.29 8/15/2023872,200 shares $9.82 million +8.3%6.1%7.3 $11.26 7/31/2023805,100 shares $10.87 million -4.7%5.7%9.6 $13.50 7/15/2023845,200 shares $11.15 million -10.5%5.9%10.6 $13.19 6/30/2023944,200 shares $12.75 million -5.6%6.6%11.4 $13.50 6/15/20231,000,000 shares $14.48 million -2.0%7.0%11.9 $14.48 5/31/20231,020,000 shares $14.46 million +1.0%7.2%11.5 $14.18 5/15/20231,010,000 shares $14.43 million -1.9%N/A10.6 $14.29 4/30/20231,030,000 shares $16.26 million +3.7%7.3%10.6 $15.79 4/15/2023993,600 shares $15.81 million +4.4%7.0%10.2 $15.91 3/31/2023952,000 shares $16.02 million -3.9%6.7%8.4 $16.83 3/15/2023990,600 shares $15.64 million -4.8%7.0%5 $15.79 2/28/20231,040,000 shares $16.33 million +1.0%7.5%5.1 $15.70 2/15/20231,030,000 shares $16.37 million +6.1%7.4%5.1 $15.89 1/31/2023970,400 shares $17.63 million -6.7%6.9%4.7 $18.17 1/15/20231,040,000 shares $19.10 million -11.9%7.4%4.9 $18.37 12/30/20221,180,000 shares $16.50 million +0.9%8.4%5.6 $13.98 12/15/20221,170,000 shares $18.18 million +6.4%8.4%8.9 $15.54 11/30/20221,100,000 shares $16.40 million -4.4%7.9%8.9 $14.91 11/15/20221,150,000 shares $18.20 million -3.4%8.2%9.7 $15.83 10/31/20221,190,000 shares $19.66 million +2.6%8.5%9.6 $16.52 10/15/20221,160,000 shares $18.10 million +7.4%8.2%8.9 $15.60 9/30/20221,080,000 shares $16.97 million +24.0%7.7%8.1 $15.71 9/15/2022871,200 shares $14.84 million -6.0%6.2%6.1 $17.03 8/31/2022927,000 shares $16.91 million -10.9%6.6%5.9 $18.24Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> JYNT Short Interest - Frequently Asked Questions What is Joint's current short interest? Short interest is the volume of Joint shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 798,500 shares of JYNT short. Learn More on Joint's current short interest. What is a good short interest ratio for Joint? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JYNT shares currently have a short interest ratio of 9.0. Learn More on Joint's short interest ratio. Which institutional investors are shorting Joint? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Joint: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Joint's short interest increasing or decreasing? Joint saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 798,500 shares, an increase of 2.2% from the previous total of 781,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Joint's short interest compare to its competitors? Here is how the short interest of companies compare to Joint: Cardiff Oncology, Inc. (8.93%), Veru Inc. (7.55%), Atossa Therapeutics, Inc. (9.86%), Akoya Biosciences, Inc. (4.74%), INmune Bio, Inc. (12.66%), Alimera Sciences, Inc. (0.21%), Profound Medical Corp. (1.28%), 908 Devices Inc. (5.16%), Acumen Pharmaceuticals, Inc. (2.40%), Semler Scientific, Inc. (4.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Joint stock? Short selling JYNT is an investing strategy that aims to generate trading profit from Joint as its price is falling. JYNT shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Joint? A short squeeze for Joint occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JYNT, which in turn drives the price of the stock up even further. How often is Joint's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JYNT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Cardiff Oncology Short Squeeze Veru Short Squeeze Atossa Therapeutics Short Squeeze Akoya Biosciences Short Squeeze INmune Bio Short Squeeze Alimera Sciences Short Squeeze Profound Medical Short Squeeze 908 Devices Short Squeeze Acumen Pharmaceuticals Short Squeeze Semler Scientific Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JYNT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace